Eli Lilly expects full-year adjusted earnings of $35.00 to $36.00 per share, compared to $35.50 to $36.50. Eli Lilly raised its full-year results guidance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.